Establishment of in vivo direct gene transfer system into joint using HVJ-liposome

HVJ-脂质体体内直接基因转移系统的建立

基本信息

  • 批准号:
    07557098
  • 负责人:
  • 金额:
    $ 13.57万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1997
  • 项目状态:
    已结题

项目摘要

We previously established a transfection method of intra-articular injection using Sendai virus/HVj in vivo. In this study we constructed and transfected genes into an animal arthritis model in vivo as well as into human synovial fibroblasts obtained from patients with rheumatoid arthritis (RA) in vitro, in search of possibility of gene therapy for RA.Furthermore we achieved a novel transfection method into ligaments in animal models and investigated in vivo effect of transfection of a gene relating to wound healing.I.Anti-inflammatory effect in an arthritis modelWe constructed a "decoy" against transcription factor, NFkB which closely associated with production of inflammatory cytokines and expression of adhesion molecules. Its intra-articular transfection in CIA rats showed significant improvement of arthritic grades, paw swelling and arthritis index, and also markedly suppressed histological findings of joint destruction.Next we constructed plasmid DNA encoding p21 locating downstream of p53, the mutation of which had repeatedly been reported in RA.p21 is also thought to associate with apoptosis. The transfection of the gene into human synovial fibroblasts from RA patients by use of HVJ-liposomes demonstrated apoptosis of the cells as well as marked suppression of cell proliferation in vitro.2. Ligament healing modelWe established a novel method of direct transfection in rat patellar ligaments by intra-arterial delivery of HVJ-liposomes. Moreover we transfected plasmid DNA encoding hepatocyte growth factor (HGF) into healing patellar ligament in rats and observed the expression of collagen type I with parallel alignment of fibers, which resembled normal ligaments.
我们先前建立了一种使用仙台病毒/HVj在体内关节内注射的转染方法。在这项研究中,我们构建并转染基因到体内动物关节炎模型以及体外从类风湿性关节炎(RA)患者获得的人滑膜成纤维细胞中,在此基础上,我们建立了一种新的基因转染方法,并在动物模型中研究了与创伤愈合相关的基因转染的体内效果。在关节炎模型中的炎症作用我们构建了针对转录因子NF κ B的“诱饵”,NF κ B与炎性细胞因子的产生和粘附分子的表达密切相关。其在CIA大鼠的关节内转染显示关节炎的等级,足肿胀和关节炎指数显着改善,也显着抑制关节破坏的组织学发现。接下来,我们构建了质粒DNA编码p21位于p53的下游,其突变已多次报告在RA。p21也被认为与细胞凋亡。通过HVJ脂质体转染RA患者滑膜成纤维细胞,体外实验显示该基因可诱导细胞凋亡,并显著抑制细胞增殖.韧带愈合模型我们建立了一种通过动脉内递送HVJ-脂质体直接转染大鼠髌韧带的新方法。此外,我们将编码肝细胞生长因子(HGF)的质粒DNA转染到大鼠愈合的髌韧带中,观察到I型胶原的表达,其纤维平行排列,类似于正常韧带。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakamura N., et al.: "Transient introduction of a foreign gene into healing rat patellar ligament." Journal of Clinical Investigation. 97. 226-231 (1996)
Nakamura N.等人:“将外源基因瞬时引入愈合的大鼠髌韧带中。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomita T,Shimaoka Y,Kashiwagi N,et al.: "Enhanced expression of CD14 antigen on myeloid lineage cells derived from the bone marrow of patients with severe rheumatoid arthritis." J Rheumatol. 24. 465-469 (1997)
Tomita T、Shimaoka Y、Kashiwagi N 等人:“来自严重类风湿关节炎患者骨髓的骨髓谱系细胞上 CD14 抗原的表达增强。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura N,Horibe S,Tomita T,et al.: "Early effect of in vivo introduction of platelet-derived growth factor (PDGF) gene into healing patellar ligament." Trans ORS. 21. 193 (1996)
Nakamura N、Horibe S、Tomita T 等人:“将血小板衍生生长因子 (PDGF) 基因体内引入愈合髌韧带的早期效果。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamura N., et al.: "Early effect of in vivo introduction of platelet-derived growth factor(PDGF)gene into healing patellar ligament." Trans ORS. 21. 193 (1996)
Nakamura N. 等人:“将血小板衍生生长因子 (PDGF) 基因体内引入愈合髌骨韧带的早期效果。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomita T., et al.: "In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ(Sendai virus)and liposomes." Arthritis and Rheumatism. 40. 901-906 (1997)
Tomita T.等人:“通过HVJ(仙台病毒)和脂质体介导的关节内注射将基因体内直接转移到关节软骨中。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OCHI Takahiro其他文献

OCHI Takahiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OCHI Takahiro', 18)}}的其他基金

Involvement of bone marrow interstitial fibroblastic cells which support the differentiation of CD(+) peripheral-blood monocytes into TRAP positive cells. In bone and cartilage destruction in rheumatoid arthritis.
骨髓间质成纤维细胞的参与支持 CD(+) 外周血单核细胞分化为 TRAP 阳性细胞。
  • 批准号:
    13470311
  • 财政年份:
    2001
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of pathological role of RA Nurse-like cells in Joint destruction of RA
RA Nurse样细胞在RA关节破坏中的病理作用分析
  • 批准号:
    11470309
  • 财政年份:
    1999
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular analysis of interaction between hematopoietic cells and nurse cells established from patients with rheumatoid arthritis
类风湿性关节炎患者造血细胞和护理细胞之间相互作用的分子分析
  • 批准号:
    09470317
  • 财政年份:
    1997
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Abnormal Myeloid Lineage Cells Expressing the Difucosyl or Trifucosyl Type 2 Chain in Bone Marrow Cells of Patinets with Severe Rheumatoid Arthritis.
患有严重类风湿性关节炎的患者骨髓细胞中表达二岩藻糖基或三岩藻糖基 2 型链的异常骨髓谱系细胞。
  • 批准号:
    06454429
  • 财政年份:
    1994
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
癌細胞特異糖鎖抗原による慢性関節リウマチ患者に対する感作療法
使用癌细胞特异性碳水化合物抗原对类风湿性关节炎患者进行敏化治疗
  • 批准号:
    04557066
  • 财政年份:
    1992
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Serum Cytotoxic Factor and its' Inhibitorin Rheumatoid Arthritis.
血清细胞毒性因子及其抑制剂类风湿性关节炎。
  • 批准号:
    04807106
  • 财政年份:
    1992
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Development of Intradermal Sensitization Therapy to Ra Patients Using Oncofetal Carbohydrate Membrane Structure
利用癌胎碳水化合物膜结构开发 Ra 患者皮内致敏疗法
  • 批准号:
    01870065
  • 财政年份:
    1992
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Myeloid cell cascade bearing onco-fetal membrane structure found in the involved epiphyseal bone marrow in patients with severe active rheumatoid arthritis
在严重活动性类风湿关节炎患者受累骨骺骨髓中发现具有癌胎膜结构的骨髓细胞级联
  • 批准号:
    02454345
  • 财政年份:
    1990
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Research Grant
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Collaborative R&D
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 13.57万
  • 项目类别:
    EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 13.57万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了